Cargando…
Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human
The 1(st) International Standard (IS) for blood coagulation factor XI (FXI), plasma, has been successfully used for potency labeling of FXI therapeutics and for diagnosis of FXI deficiency in patients. With stocks of the 1(st) IS near depletion, a replacement is required. In addition to the function...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357867/ https://www.ncbi.nlm.nih.gov/pubmed/28373973 http://dx.doi.org/10.3389/fmed.2017.00028 |
_version_ | 1782516123405647872 |
---|---|
author | Wilmot, Helen Hockley, Jason Rigsby, Peter Gray, Elaine |
author_facet | Wilmot, Helen Hockley, Jason Rigsby, Peter Gray, Elaine |
author_sort | Wilmot, Helen |
collection | PubMed |
description | The 1(st) International Standard (IS) for blood coagulation factor XI (FXI), plasma, has been successfully used for potency labeling of FXI therapeutics and for diagnosis of FXI deficiency in patients. With stocks of the 1(st) IS near depletion, a replacement is required. In addition to the functional activity value, assignment of an antigen value to the 2(nd) IS would allow harmonization of antigen assay methods and differentiation of patients who have low functional activity but normal antigen FXI levels from patients who have both low functional and antigen FXI levels. The aims of this study were, therefore, to assign FXI functional activity to the 2(nd) IS for FXI, plasma, and to additionally assign a new analyte, FXI antigen, to the same International Standard. The candidate material was prepared from double-spun, virology negative, normal plasma, which was pooled and filled into siliconized glass ampoules and subsequently freeze-dried. Assignment of the functional activity (FXI:C) value in International Units (IUs) was performed by one-stage clotting assay by 29 laboratories, relative to the 1(st) IS. The overall geometric mean (GM) was 0.71 IU/amp with extremely low inter-laboratory variability (expressed as geometric coefficient of variation) of 1.8%. The antigen value assignment was performed by 11 laboratories and was calculated relative to normal plasma pools, as is customary with new coagulation factor analytes. The amount of antigen present in 1 ml of normal plasma was taken to be 1 U. The overall GM for the antigen assays was 0.78 IU/amp with an inter-laboratory variation of 10%. The candidate (National Institute for Biological Standards and Control code, 15/180) was established by the World Health Organization (WHO) Expert Committee on Biological Standardization in 2016 as the WHO 2(nd) IS for blood coagulation FXI, plasma, with a functional activity value (FXI:C) of 0.71 IU/amp and an antigen value (FXI:Ag) of 0.78 IU/amp. |
format | Online Article Text |
id | pubmed-5357867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53578672017-04-03 Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human Wilmot, Helen Hockley, Jason Rigsby, Peter Gray, Elaine Front Med (Lausanne) Medicine The 1(st) International Standard (IS) for blood coagulation factor XI (FXI), plasma, has been successfully used for potency labeling of FXI therapeutics and for diagnosis of FXI deficiency in patients. With stocks of the 1(st) IS near depletion, a replacement is required. In addition to the functional activity value, assignment of an antigen value to the 2(nd) IS would allow harmonization of antigen assay methods and differentiation of patients who have low functional activity but normal antigen FXI levels from patients who have both low functional and antigen FXI levels. The aims of this study were, therefore, to assign FXI functional activity to the 2(nd) IS for FXI, plasma, and to additionally assign a new analyte, FXI antigen, to the same International Standard. The candidate material was prepared from double-spun, virology negative, normal plasma, which was pooled and filled into siliconized glass ampoules and subsequently freeze-dried. Assignment of the functional activity (FXI:C) value in International Units (IUs) was performed by one-stage clotting assay by 29 laboratories, relative to the 1(st) IS. The overall geometric mean (GM) was 0.71 IU/amp with extremely low inter-laboratory variability (expressed as geometric coefficient of variation) of 1.8%. The antigen value assignment was performed by 11 laboratories and was calculated relative to normal plasma pools, as is customary with new coagulation factor analytes. The amount of antigen present in 1 ml of normal plasma was taken to be 1 U. The overall GM for the antigen assays was 0.78 IU/amp with an inter-laboratory variation of 10%. The candidate (National Institute for Biological Standards and Control code, 15/180) was established by the World Health Organization (WHO) Expert Committee on Biological Standardization in 2016 as the WHO 2(nd) IS for blood coagulation FXI, plasma, with a functional activity value (FXI:C) of 0.71 IU/amp and an antigen value (FXI:Ag) of 0.78 IU/amp. Frontiers Media S.A. 2017-03-20 /pmc/articles/PMC5357867/ /pubmed/28373973 http://dx.doi.org/10.3389/fmed.2017.00028 Text en Copyright © 2017 Wilmot, Hockley, Rigsby and Gray. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Wilmot, Helen Hockley, Jason Rigsby, Peter Gray, Elaine Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human |
title | Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human |
title_full | Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human |
title_fullStr | Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human |
title_full_unstemmed | Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human |
title_short | Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human |
title_sort | establishment of the world health organization 2(nd) international standard for factor xi, plasma, human |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357867/ https://www.ncbi.nlm.nih.gov/pubmed/28373973 http://dx.doi.org/10.3389/fmed.2017.00028 |
work_keys_str_mv | AT wilmothelen establishmentoftheworldhealthorganization2ndinternationalstandardforfactorxiplasmahuman AT hockleyjason establishmentoftheworldhealthorganization2ndinternationalstandardforfactorxiplasmahuman AT rigsbypeter establishmentoftheworldhealthorganization2ndinternationalstandardforfactorxiplasmahuman AT grayelaine establishmentoftheworldhealthorganization2ndinternationalstandardforfactorxiplasmahuman |